Toxicological Evaluations of Potential Medications to Treat Drug Abuse Tender, USA - 74093049

Procurement Summary

Country : USA

Summary : Toxicological Evaluations of Potential Medications to Treat Drug Abuse

Deadline : 18 Nov 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 74093049

Document Ref. No. : N01DA-23-8939

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This is a SMALL BUSINESS SOURCES SOUGHT NOTICE to determine the availability of ALL small businesses (e.g., 8(a), Veteran-owned small businesses, service-disabled Veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, women-owned small businesses, and other small businesses) to fulfill the needs of NIH and NIDA for this future requirement. The NIDA Medications Discovery and Toxicology Branch has the mission to facilitate, through preclinical medications discovery and safety assessment efforts, the translation of basic research findings into pharmacotherapies for the treatment of substance use disorders. When preclinical development candidates are identified, this contract provides a resource for the development of safety data that support filing Investigational New Drug (IND) applications and New Drug Application(s) (NDA) to the U.S. Food and Drug Administration (FDA). In this context, the primary objective of this research and development contract is to support preclinical safety pharmacology studies and preclinical acute and repeat dose toxicology studies in rodents, rabbits, dogs and/or nonhuman primates (monkeys) on test articles that are potential pharmacotherapies (medications) to treat substance use disorders. It is anticipated that NIDA will use the results of these preclinical studies in IND and NDA filings with the FDA in accordance with FDA Guidances, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines and Good Laboratory Practice for Nonclinical Laboratory Studies (GLP) regulations. Please see the attachment for more details.
Active Contract Opportunity
Notice ID : N01DA-23-8939
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Nov 03, 2022 10:34 am EDT
Original Response Date: Nov 18, 2022 11:00 am EST
Inactive Policy: Manual
Original Inactive Date: Dec 15, 2022
Initiative: None

Classification
Original Set Aside:
Product Service Code: AN11 - Health R&D Services; Health care services; Basic Research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance:

Documents

 Tender Notice

N01DA-23-8939-Sources-Sought-Notice.pdf